HBV Citations List: December 2024

Literature Citations

1. Discovery of Novel Small Molecules Targeting Hepatitis B Virus Core Protein from Marine Natural Products with HiBiT-Based High-Throughput Screening. Huang, C., Y. Jin, P. P. Fu, K. Y. Hu, M. X. Wang, W. J. Zai, T. Hua, X. L. Song, J. Y. Ye, Y. Q. Zhang, G. Luo, H. Y. Wang, J. X. Liu, J. L. Chen, X. W. Li and Z. H. Yuan. Acta Pharmaceutica Sinica B, 2024. 14(11): 4914-4933. ISI[001364532100001].
[WOS]. HBV­_12_2024.

2. New Thiourea Derivatives that Target the Episomal Silencing SMC5 Protein to Inhibit HBx-Dependent Viral DNA Replication and Gene Transcription. Kumar, J., A. Singh, P. Tyagi, D. Sharma, S. K. Sarin and V. Kumar. Virusdisease, 2024. 35(4): 577-588. PMID[39677840]. PMCID[PMC11635082].
[PubMed]. HBV­_12_2024.

3. Design, Synthesis, and Biological Evaluation of Novel 2-Heteroaryloxazolidine-4-one Derivatives as Novel HBV Capsid Assembly Modulators. Tao, X. F., Y. Wang, Y. W. Wang, Y. X. Jin, Y. X. Wang, J. S. Li and R. Sheng. Biological & Pharmaceutical Bulletin, 2024. 47(12): 2003-2010. ISI[001376815600002].
[WOS]. HBV­_12_2024.

4. The Discovery and Preclinical Profile of ALG-000184, a Prodrug of the Potent Hepatitis B Virus Capsid Assembly Modulator ALG-001075. Vendeville, S., F. Amblard, L. Bassit, L. N. Beigelman, L. M. Blatt, X. Chen, L. Chou, D. B. Kum, S. Chanda, J. Deval, X. Geng, K. Gupta, A. Jekle, H. Hu, X. Hu, H. Kang, C. Liu, J. Liu, D. C. McGowan, D. L. Misner, P. Raboisson, A. A. Sanchez, V. Serebryany, A. D. Stoycheva, J. A. Symons, H. Tan, H. Vanrusselt, C. Williams, M. Welch, L. Zhang, Q. Zhang, Y. Zhang, R. F. Schinazi, D. B. Smith and Y. Debing. Journal of Medicinal Chemistry, 2024. 67(23): 21126-21142. PMID[39575679].
[PubMed]. HBV­_12_2024.

5. Berberine Promotes K(48)-Linked Polyubiquitination of HNF4α,Leading to the Inhibition of HBV Replication. Yamashita, A., H. Kasai, S. Maekawa, T. Tanaka, Y. Akaike, A. Ryo, N. Enomoto and K. Moriishi. Antiviral Research, 2024. 232: 106027. PMID[39489302].
[PubMed]. HBV­_12_2024.

Patent Citations

This month, no relevant HBV patents were identified.